Difference between revisions of "1.3.6.1.4.1.19376.1.3.11.35/static-2015-11-13T190732"

From pubswiki
Jump to navigation Jump to search
(Automatic ADBot page (ac63f2e2f04feb663530fbc99e22743c590f5cbc))
(Automatic ADBot page (ac63f2e2f04feb663530fbc99e22743c590f5cbc))
Line 1: Line 1:
  
<table xmlns="http://www.w3.org/1999/xhtml" width="100%" border="0" cellspacing="3" cellpadding="2" class="artdecor " style="background: transparent;"><tr class="desclabel"><td colspan="4">This terminology is a snapshot as of . Terminologies may evolve over time. If you need recent (dynamic) versions of this terminology, please retrieve it from the source.</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Id</th><td style="text-align: left;">1.3.6.1.4.1.19376.1.3.11.35</td><th style="width: 20em; text-align: left;">Effective Date</th><td style="text-align: left;">2015‑11‑13 19:07:32</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Status</th><td style="text-align: left;">[[File:Kyellow.png|14px]] Draft</td><th style="width: 20em; text-align: left;">Version Label</th><td style="text-align: left;">1st rev. (2013)</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Name</th><td style="text-align: left;">icd-o-3-differentiation</td><th style="width: 20em; text-align: left;">Display Name</th><td style="text-align: left;">ICD-O-3 Differentiation</td></tr><tr style="vertical-align: top;"><td style="text-align: left;" colspan="4"><table id="valueSetDescTable" width="100%" border="0" cellspacing="3" cellpadding="2" class="artdecor treetable" style="background: transparent;"><tr class="desclabel"><td style="height: 1.5em;">Description</td></tr><tr><td><div>Coding the cellular differentiation of malignant tumors, either the grade of malignancy (differentiation), or the cell line differentiation, coded by the second digit after the slash in ICD-O-3 Morphology axi</div></td></tr></table></td></tr><tr style="vertical-align: top;"><td colspan="4"><table id="valueSetUsageTable" width="100%" border="0" cellspacing="3" cellpadding="2" class="artdecor treetable" style="background: transparent;"><tr class="desclabel"><td style="height: 1.5em;">Usage: 2</td></tr><tr><td><div><table width="100%" border="0" cellspacing="3" cellpadding="2" class="artdecor " style="background: transparent;"><tr><th>Id</th><th>Name</th><th>Type</th></tr><tr><th style="text-align: left;" colspan="3">Data Set</th></tr><tr><td>psr-data&#8203;element-104</td><td>Grading/Immunophenotype</td><td> DYNAMIC </td></tr><tr><th style="text-align: left;" colspan="3">Template </th></tr><tr><td>1.3.6.1.4.1.19376.1.3.10.9.39</td><td>ICD-O-3 Differentiation (2.0)</td><td> STATIC </td></tr></table></div></td></tr></table></td></tr><tr class="headinglabel"><th style="vertical-align: top; text-align: left;">2 Source Code Systems</th><td colspan="3" class="tabtab"><div style="width: 100%; margin: 4px 0px; background-color: #fff;">2.16.840.1.113883.6.43.1 - <i>International Classification of Diseases for Oncology, version 3.</i> - FHIR: <i>urn:oid:2.16.840.1.113883.6.43.1</i> - HL7 V2: <i>ICDO3</i></div><div style="width: 100%; margin: 4px 0px; background-color: #eee;">2.16.840.1.113883.5.1008 - <i>Null Flavor</i> - FHIR: <i>http://terminology.hl7.org/CodeSystem/v3-NullFlavor</i> - HL7 V2: <i>NULLFL</i></div></td></tr><tr><td colspan="4" class="tabtab"><table width="100%" border="0" cellspacing="0" cellpadding="5" id="transactionTable" class="artdecor treetable" style="background: transparent;"><tr style="background-color: #F6F3EE;"><th style="text-align: left;">Level/ Type</th><th style="width: 100px; text-align: left;">Code</th><th style="text-align: left;">Display Name</th><th style="width: 200px; text-align: left;">Code System</th><th style="vertical-align: top; text-align: left;">Description</th></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">1</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">well (highly) differentiated</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">2</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">moderately differentiated</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">3</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">poorly differentiated</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">undifferentiated resp. anaplastic</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">T-cell differentiation in lymphomas and leukemias</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">6</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">B-cell differentiation, pre-B-cells, B-precursor cells in lymphomas and leukemias</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">7</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">Null-cell, non-B-nonT-cell differentiation in lymphomas and leukemias</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">8</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">NK (natural killer)-cell differentiation in lymphomas and leukemias</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">9</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">grading not applied, not applicable, unknown; cell type not assessed or unknown</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">ASKU</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Asked but unknown</div></td><td style="vertical-align: top;">Null Flavor</td><td style="vertical-align: top;"></td></tr><tr><td colspan="5"><hr /></td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">ASKU</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Asked but unknown</div></td><td style="vertical-align: top;">Null Flavor</td><td style="vertical-align: top;"></td></tr></table></td></tr><tr class="desclabel"><td colspan="4">Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.</td></tr></table>
+
<table xmlns="http://www.w3.org/1999/xhtml" width="100%" border="0" cellspacing="3" cellpadding="2" class="artdecor " style="background: transparent;"><tr class="desclabel"><td colspan="4">This terminology is a snapshot as of . Terminologies may evolve over time. If you need recent (dynamic) versions of this terminology, please retrieve it from the source.</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Id</th><td style="text-align: left;">1.3.6.1.4.1.19376.1.3.11.35</td><th style="width: 20em; text-align: left;">Effective Date</th><td style="text-align: left;">2015‑11‑13 19:07:32</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Status</th><td style="text-align: left;">[[File:Kyellow.png|14px]] Draft</td><th style="width: 20em; text-align: left;">Version Label</th><td style="text-align: left;">1st rev. (2013)</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Name</th><td style="text-align: left;">icd-o-3-differentiation</td><th style="width: 20em; text-align: left;">Display Name</th><td style="text-align: left;">ICD-O-3 Differentiation</td></tr><tr style="vertical-align: top;"><td style="text-align: left;" colspan="4"><table id="valueSetDescTable" width="100%" border="0" cellspacing="3" cellpadding="2" class="artdecor treetable" style="background: transparent;"><tr class="desclabel"><td style="height: 1.5em;">Description</td></tr><tr><td><div>Coding the cellular differentiation of malignant tumors, either the grade of malignancy (differentiation), or the cell line differentiation, coded by the second digit after the slash in ICD-O-3 Morphology axi</div></td></tr></table></td></tr><tr style="vertical-align: top;"><td colspan="4"><table id="valueSetUsageTable" width="100%" border="0" cellspacing="3" cellpadding="2" class="artdecor treetable" style="background: transparent;"><tr class="desclabel"><td style="height: 1.5em;">Usage: 2</td></tr><tr><td><div><table width="100%" border="0" cellspacing="3" cellpadding="2" class="artdecor " style="background: transparent;"><tr><th>Id</th><th>Name</th><th>Type</th></tr><tr><th style="text-align: left;" colspan="3">Data Set</th></tr><tr><td>psr-data&#8203;element-104</td><td>Grading/Immunophenotype</td><td> DYNAMIC </td></tr><tr><th style="text-align: left;" colspan="3">Template </th></tr><tr><td>1.3.6.1.4.1.19376.1.3.10.9.39</td><td>ICD-O-3 Differentiation (2.0)</td><td> STATIC </td></tr></table></div></td></tr></table></td></tr><tr class="headinglabel"><th style="vertical-align: top; text-align: left;">2 Source Code Systems</th><td colspan="3" class="tabtab"><div style="width: 100%; margin: 4px 0px; background-color: #fff;">2.16.840.1.113883.5.1008 - <i>Null Flavor</i> - FHIR: <i>http://terminology.hl7.org/CodeSystem/v3-NullFlavor</i> - HL7 V2: <i>NULLFL</i></div><div style="width: 100%; margin: 4px 0px; background-color: #eee;">2.16.840.1.113883.6.43.1 - <i>International Classification of Diseases for Oncology, version 3.</i> - FHIR: <i>urn:oid:2.16.840.1.113883.6.43.1</i> - HL7 V2: <i>ICDO3</i></div></td></tr><tr><td colspan="4" class="tabtab"><table width="100%" border="0" cellspacing="0" cellpadding="5" id="transactionTable" class="artdecor treetable" style="background: transparent;"><tr style="background-color: #F6F3EE;"><th style="text-align: left;">Level/ Type</th><th style="width: 100px; text-align: left;">Code</th><th style="text-align: left;">Display Name</th><th style="width: 200px; text-align: left;">Code System</th><th style="vertical-align: top; text-align: left;">Description</th></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">1</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">well (highly) differentiated</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">2</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">moderately differentiated</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">3</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">poorly differentiated</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">undifferentiated resp. anaplastic</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">T-cell differentiation in lymphomas and leukemias</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">6</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">B-cell differentiation, pre-B-cells, B-precursor cells in lymphomas and leukemias</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">7</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">7</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">Null-cell, non-B-nonT-cell differentiation in lymphomas and leukemias</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">8</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">8</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">NK (natural killer)-cell differentiation in lymphomas and leukemias</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">9</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">9</div></td><td style="vertical-align: top;">International Classification of Diseases for Oncology, version 3.</td><td style="vertical-align: top;">grading not applied, not applicable, unknown; cell type not assessed or unknown</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">ASKU</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Asked but unknown</div></td><td style="vertical-align: top;">Null Flavor</td><td style="vertical-align: top;"></td></tr><tr><td colspan="5"><hr /></td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">ASKU</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">Asked but unknown</div></td><td style="vertical-align: top;">Null Flavor</td><td style="vertical-align: top;"></td></tr></table></td></tr><tr class="desclabel"><td colspan="4">Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.</td></tr></table>
<!--9b12b4330438b6ff27e92e638d4431f74005b95f-->
+
<!--3049b80169a5a3b546f6ec66f6ad0c852edb84bc-->

Revision as of 15:33, 21 January 2024

This terminology is a snapshot as of . Terminologies may evolve over time. If you need recent (dynamic) versions of this terminology, please retrieve it from the source.
Id1.3.6.1.4.1.19376.1.3.11.35Effective Date2015‑11‑13 19:07:32
StatusKyellow.png DraftVersion Label1st rev. (2013)
Nameicd-o-3-differentiationDisplay NameICD-O-3 Differentiation
Description
Coding the cellular differentiation of malignant tumors, either the grade of malignancy (differentiation), or the cell line differentiation, coded by the second digit after the slash in ICD-O-3 Morphology axi
Usage: 2
IdNameType
Data Set
psr-data​element-104Grading/Immunophenotype DYNAMIC
Template
1.3.6.1.4.1.19376.1.3.10.9.39ICD-O-3 Differentiation (2.0) STATIC
2 Source Code Systems
2.16.840.1.113883.5.1008 - Null Flavor - FHIR: http://terminology.hl7.org/CodeSystem/v3-NullFlavor - HL7 V2: NULLFL
2.16.840.1.113883.6.43.1 - International Classification of Diseases for Oncology, version 3. - FHIR: urn:oid:2.16.840.1.113883.6.43.1 - HL7 V2: ICDO3
Level/ TypeCodeDisplay NameCode SystemDescription
0‑L
1
1
International Classification of Diseases for Oncology, version 3.well (highly) differentiated
0‑L
2
2
International Classification of Diseases for Oncology, version 3.moderately differentiated
0‑L
3
3
International Classification of Diseases for Oncology, version 3.poorly differentiated
0‑L
4
4
International Classification of Diseases for Oncology, version 3.undifferentiated resp. anaplastic
0‑L
5
5
International Classification of Diseases for Oncology, version 3.T-cell differentiation in lymphomas and leukemias
0‑L
6
6
International Classification of Diseases for Oncology, version 3.B-cell differentiation, pre-B-cells, B-precursor cells in lymphomas and leukemias
0‑L
7
7
International Classification of Diseases for Oncology, version 3.Null-cell, non-B-nonT-cell differentiation in lymphomas and leukemias
0‑L
8
8
International Classification of Diseases for Oncology, version 3.NK (natural killer)-cell differentiation in lymphomas and leukemias
0‑L
9
9
International Classification of Diseases for Oncology, version 3.grading not applied, not applicable, unknown; cell type not assessed or unknown
0‑L
ASKU
Asked but unknown
Null Flavor

0‑L
ASKU
Asked but unknown
Null Flavor
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.